Updated for HOE Pharmaceuticals , Taisho Pharm (大正製藥),Shin Biofermin S (新表飛鳴S片)

Advertiser: HOE Pharmaceuticals ,Taisho Pharm (大正製藥),Shin Biofermin S (新表飛鳴S片)

Admendment:  HOE Pharmaceuticals , Taisho Pharm (大正製藥),Shin Biofermin S (新表飛鳴S片) have been amended

Result: Adspend of would be affected

Affected Period:May 2021

Affected Media:MTR

 

Action: 21pmtr0417302,21pmtr0515306

 

Some appearances of 21pmtr0417302 have been moved to 21pmtr0515306

 

From

HOE Pharmaceuticals  >       Ezerra Series   (34%)

Taisho Pharm (大正製藥) >    Medical Plaster (脫苦海膏布)        (33%)

Taisho Pharm (大正製藥) >    Counterpain (肯得止痛膏)     (33%)

change to

Taisho Pharm (大正製藥)>     Counterpain (肯得止痛膏)     (25%)

Shin Biofermin S (新表飛鳴S片)> Gastroenterology (乳酸菌理腸劑) (25%)

HOE Pharmaceuticals>   Ezerra Series   (25%)

Taisho Pharm (大正製藥)>     Medical Plaster (脫苦海膏布)        (25%)

Advertiser Updated for Taisho Pharm (大正製藥)

Advertiser: Taisho Pharm (大正製藥)

Amendment: Advertiser of Taisho Pharm (大正製藥) have been amended

Result: Adspend of Advertiser would be affected

Affected Period: 02 July 2020 to 01 October 2020

Affected Media: TVC,BANNER

From

Pharmaceuticals & Healthcare > Muscle & Bone  

Counterpain (肯得止痛膏) > Pain Relief Patch (肯德外用鎮痛貼)  

To

Pharmaceuticals & Healthcare > Muscle & Bone

Taisho Pharm (大正製藥) > Pain Relief Patch (肯德外用鎮痛貼) 

Advertiser / Brand Updated for Taisho Pharm (大正製藥)

Advertiser: Taisho Pharm (大正製藥)

Amendment:Advertiser / Brand of Taisho Pharm (大正製藥) have been amended

Result: Adspend of Advertiser / Brand would be affected

Affected Period: 16 May 2002 to 29 September 2020

Affected Media: PRINT,BANNER,SOC,MTR,KCRC,BUS BODY,TVC

From

Pharmaceuticals & Healthcare > Muscle & Bone

Counterpain (肯得止痛膏) > Analgesic Balm (止痛膏) 

To

Pharmaceuticals & Healthcare > Muscle & Bone

Taisho Pharm (大正製藥) > Counterpain (肯得止痛膏)

Category / Sub-Category / Advertiser / Brand / Brand Percentage Updated for Taisho Pharm (大正製藥)

Advertiser: Taisho Pharm (大正製藥)

Admendment: Category / Sub-Category / Advertiser / Brand / Brand Percentage of Taisho Pharm (大正製藥) have been amended

Result: Adspend of Category / Sub-Category / Advertiser / Brand / Brand Percentage would be affected

Affected Period: 01 July 2019 to 10 September 2019

Affected Media: BUS



Action: 19bus0701021



From

Beverages > Vitaminized & Energy Drinks

Taisho Pharm (大正製藥) > Libogen (力保健 / 力保健美) (100%)

To

Pharmaceuticals & Healthcare > Gastroenterology

Shin Biofermin S (新表飛鳴S片) > Gastroenterology (乳酸菌理腸劑) (50%)

Pharmaceuticals & Healthcare > Gastroenterology

Shin Biofermin S (新表飛鳴S片) > Gastroenterology (乳酸菌理腸劑) (50%)